Effectiveness of 2D fingerprints for scaffold hopping.
暂无分享,去创建一个
Peter Willett | Eleanor J. Gardiner | Eleanor J Gardiner | John D Holliday | Caroline O'Dowd | P. Willett | J. Holliday | C. O'Dowd
[1] Ajay N. Jain,et al. Effects of inductive bias on computational evaluations of ligand-based modeling and on drug discovery , 2008, J. Comput. Aided Mol. Des..
[2] J. Gasteiger,et al. Chemoinformatics: A Textbook , 2003 .
[3] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[4] Robert P Sheridan,et al. Chemical similarity searches: when is complexity justified? , 2007, Expert opinion on drug discovery.
[5] Peter Willett,et al. Similarity methods in chemoinformatics , 2009, Annu. Rev. Inf. Sci. Technol..
[6] Sebastian G. Rohrer,et al. Maximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data , 2009, J. Chem. Inf. Model..
[7] Jérôme Hert,et al. Turbo similarity searching: Effect of fingerprint and dataset on virtual‐screening performance , 2009, Stat. Anal. Data Min..
[8] Yvonne C. Martin,et al. Application of Belief Theory to Similarity Data Fusion for Use in Analog Searching and Lead Hopping , 2008, J. Chem. Inf. Model..
[9] Robert C. Glen,et al. Similarity Metrics and Descriptor Spaces – Which Combinations to Choose? , 2006 .
[10] Gisbert Schneider,et al. Scaffold‐Hopping: How Far Can You Jump? , 2006 .
[11] Peter Willett,et al. Enhancing the Effectiveness of Ligand‐Based Virtual Screening Using Data Fusion , 2006 .
[12] G. Schneider,et al. Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.
[13] Yong-Jin Xu,et al. Using Molecular Equivalence Numbers to Visually Explore Structural Features that Distinguish Chemical Libraries. , 2002 .
[14] Hongyu Zhao,et al. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective. , 2007, Drug discovery today.
[15] M. Stahl,et al. Scaffold hopping. , 2004, Drug discovery today. Technologies.
[16] J. Bajorath,et al. Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening. , 2010, Journal of medicinal chemistry.
[17] Tudor I. Oprea,et al. Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection? , 2008, J. Comput. Aided Mol. Des..
[18] P Willett,et al. Grouping of coefficients for the calculation of inter-molecular similarity and dissimilarity using 2D fragment bit-strings. , 2002, Combinatorial chemistry & high throughput screening.
[19] Y. Martin,et al. Beyond QSAR: Lead Hopping to Different Structures , 2009 .
[20] S. Siegel,et al. Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.
[21] Lisa Peltason,et al. Molecular Similarity Analysis in Virtual Screening , 2009 .
[22] Peter Willett,et al. Analysis and use of fragment-occurrence data in similarity-based virtual screening , 2009, J. Comput. Aided Mol. Des..
[23] P. Willett,et al. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.
[24] Nathan Brown,et al. On scaffolds and hopping in medicinal chemistry. , 2006, Mini reviews in medicinal chemistry.
[25] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[26] Andrew R. Leach,et al. An Introduction to Chemoinformatics , 2003 .
[27] Woody Sherman,et al. Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.
[28] Woody Sherman,et al. Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..
[29] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.